semaglutide europe Sales soar at Danish firm behind weight-loss drug | Pharmaceuticals industry European Medicines Agency recommends weight
Description
You should have a thorough discussion with your healthcare provider about your medical history and any possible risks and side effects before starting semaglutide as part of a weight loss program
Eli Lilly confirmed this in their Phase 1 pharmacokinetic study: no clinically relevant differences in total tirzepatide exposure between the abdomen, thigh, and upper arm
Sources: [1] Jastreboff AM, et al
Medical Oversight: Evaluation, Labs, And Ongoing Monitoring The Optimal Medical Group program includes a structured medical evaluation at the start, with a review of health history, current medications, and weight-related risk factors
